Amgen wins patent case
Thousand Oaks-based Amgen had a big win in court on Sept. 20, as a federal court in New Jersey upheld multiple Amgen patents for its psoriasis treatment, Otezla. Amgen filed a patent infringement lawsuit earlier this year against two companies, Sandoz and Zydus Pharmaceuticals, claiming that their generic versions of Otezla infringed upon at least Read More →
Changing of the guard at CenCal as longtime CEO set to retire
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
SLO County joins Santa Barbara and Ventura with new mask mandate
Public health officials in San Luis Obispo, Santa Barbara and Ventura counties now require everyone to wear face coverings in all indoor public settings to protect against COVID-19, after San Luis Obispo County reinstated its mask mandate on Aug. 31. Citing rising case rates in San Luis Obispo County, Health Officer Dr. Penny Borenstein issued Read More →
Our View: Troubling signs in SLO’s fight against COVID; A golden opportunity at Channel Islands Harbor
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Central Coast Health Watch: Ventura County masks up; Cottage honored; CenCal pays for senior meals
Ventura County’s public health officer, Dr. Robert Levin, issued an order requiring masks indoors in most public settings starting Aug. 23, joining a mask mandate already in effect in Santa Barbara County. San Luis Obispo County is not requiring masks, though it has the region’s highest rate of new COVID-19 cases and lowest vaccination rate. Read More →
Arcutis starts new Phase 3 trial
Arcutis Biotherapeutics announced Aug. 25 that it has enrolled the first patient in a Phase 3 clinical trial to evaluate ARQ-154, its topical foam, as a treatment for scalp and body psoriasis. The foam is a once-daily formulation of roflumilast, a phosphodiesterase type 4 inhibitor that the company is developing to treat two skin conditions: Read More →
Dignity, Anthem settle health coverage dispute
Dignity Health and Anthem Blue Cross have reached a new multi-year contract agreement that allows Anthem-insured customers to maintain in-network access to Dignity Health providers and facilities. On Aug. 16, the two organizations announced the agreement, which returns Dignity Health providers in the Tri-Counties to Anthem health plans, with no gap in coverage. The contract Read More →
